Rapid Response From Clinical Trials at the Summit: Transforming Retinal Disease Care With New Data This activity is supported by an educational grant from Genentech, a member of the Roche Group.

IoO Seminar Series with Eyal Bannin Title: Novel Gene- and Cell-based Therapies for Retinal and Macular Degenerations: The Hadassah Experience Back to All Events ...

Recent research introduces a soft, injectable material designed for use in the eye to help protect and support damaged retinal tissue. It offers a gentle, biocompatible way to stabilize the inner ...

Neovascular age-related macular degeneration (AMD) requires regular and timely intravitreal injections of anti-vascular endothelial growth factor (VEGF) for effective management. However, ...

Opus Genetics, Inc. announced that the company entered into an agreement with the Retinal Degeneration Fund (RD Fund), the venture philanthropy arm of the Foundation Fighting Blindness through which ...

A new study identifies how the molecule, called ApoM, can clear harmful cholesterol deposits linked to macular degeneration as well as certain types of heart ailments.

Vertical and horizontal relative peripheral refraction (RPR) are associated with faster axial length progression and higher risk of incident myopia.

Notably, thinning of the inner retinal layers—such as the ganglion cell layer (GCL) and retinal nerve fiber layer (RNFL)—has been clearly associated with impaired local neurovascular coupling, ...